Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
3.150
+0.120 (3.96%)
At close: Nov 7, 2025, 4:00 PM EST
3.270
+0.120 (3.81%)
After-hours: Nov 7, 2025, 7:28 PM EST
Immix Biopharma Employees
As of December 31, 2024, Immix Biopharma had 21 total employees, including 18 full-time and 3 part-time employees. The number of employees increased by 4 or 23.53% compared to the previous year.
Employees
21
Change (1Y)
4
Growth (1Y)
23.53%
Revenue / Employee
n/a
Profits / Employee
-$1,122,040
Market Cap
102.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21 | 4 | 23.53% |
| Dec 31, 2023 | 17 | 6 | 54.55% |
| Dec 31, 2022 | 11 | 9 | 450.00% |
| Dec 31, 2021 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IMMX News
- 1 day ago - Immix Biopharma: I Am Surprised To Reaffirm A 'Buy' - Seeking Alpha
- 5 days ago - Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025 - GlobeNewsWire
- 25 days ago - Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 4 weeks ago - Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting - GlobeNewsWire
- 5 weeks ago - Immix Biopharma to Present at the 37th Annual Piper Sandler Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Immix Biopharma Announces 50% Enrollment Milestone Surpassed in its ongoing relapsed/refractory AL Amyloidosis Clinical Trial, NEXICART-2 - GlobeNewsWire
- 2 months ago - Nancy T. Chang, Proven Biotechnology Leader, Joins Immix Biopharma Board of Directors - GlobeNewsWire
- 2 months ago - Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang - GlobeNewsWire